Rovi Pharmaceuticals Laboratories

This study looked at how well Risperidone ISM works in real-world settings for people with schizophrenia who were hospitalized after a relapse. Researchers tracked 275 patients over 56 days to see if their symptoms and daily functioning improved. The goal was to understand the dr…

This early-phase study tested a new long-acting risperidone injection given every three months in 58 adults with stable schizophrenia. The goal was to check safety and how the drug moves through the body. Participants were already taking daily risperidone pills, so this shot aims…